Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.063 CHF | -0.94% | +7.14% | +53.66% |
01/05 | SIX Swiss Exchange Approves Delay in Spexis' FY23 Annual Report Publication | MT |
17/04 | Santhera Pharmaceuticals Terminates Cystic Fibrosis Drug License Deal with Spexis | MT |
- Stock Market
- Equities
- POLN Stock
- News Spexis AG
- Transcripts